A Plasma Cytokine and Angiogenic Factor (CAF) Analysis for Selection of Bevacizumab Therapy in Patients With Metastatic Colorectal Cancer
Scientific Reports - United Kingdom
doi 10.1038/srep17717
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2015
Authors
Publisher
Springer Science and Business Media LLC